about
Kirby-Bauer disc approximation to detect inducible third-generation cephalosporin resistance in EnterobacteriaceaeDio-Sensimedia: a novel culture medium for rapid detection of extended spectrum beta-lactamasesEscherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in UgandaDetecting a quasi-stable imine species on the reaction pathway of SHV-1 β-lactamase and 6β-(hydroxymethyl)penicillanic acid sulfoneMicrobial based assay for specific detection of β-lactam group of antibiotics in milkAntibiogram and plasmid profiling of carbapenemase and extended spectrum Beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in Abeokuta, South western, Nigeria.Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coliPrevalence of derepressed ampC mutants and extended-spectrum beta-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12.Antibiotic susceptibility pattern in urinary isolates of gram negative bacilli with special reference to AmpC β-lactamase in a tertiary care hospital.Low-virulence Citrobacter species encode resistance to multiple antimicrobials.Detection of a bla(SHV) extended-spectrum {beta}-lactamase in Salmonella enterica serovar Newport MDR-AmpCEmergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan.Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.Beyond Susceptible and Resistant, Part I: Treatment of Infections Due to Gram-Negative Organisms With Inducible β-LactamasesRapid, low-cost fluorescent assay of β-lactamase-derived antibiotic resistance and related antibiotic susceptibility.Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection methodExtended-spectrum beta-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria.Comparison of ESBL--and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in AustriaInhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.Resistant plasmid profile analysis of multidrug resistant Escherichia coli isolated from urinary tract infections in Abeokuta, Nigeria.Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.Predominant Dissemination of PVL-Negative CC89 MRSA with SCCmec Type II in Children with Impetigo in Japan.Haemophilus parainfluenzae as a marker of the upper respiratory tract microbiota changes under the influence of preoperative prophylaxis with or without postoperative treatment in patients with lung cancer.Zinc Finger Nuclease: A New Approach to Overcome Beta-Lactam Antibiotic Resistance.Risk Factor Analysis in Clinical Isolates of ESBL and MBL (Including NDM-1) Producing Escherichia coli and Klebsiella Species in a Tertiary Care HospitalHigh prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.Antimicrobial resistance in Haemophilus influenzaePrevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience.Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit.Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward.Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.Reflection paper on the use of third and fourth generation cephalosporins in food producing animals in the European Union: development of resistance and impact on human and animal health.Recent developments of biological reporter technology for detecting gene expression.Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin.Use of DNA microarrays for rapid genotyping of TEM beta-lactamases that confer resistance.Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and Paratyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study.In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
P2860
Q24794095-036672E8-4382-49EE-A6B1-D4E647B109C5Q24805202-FF9D5F0A-5085-47FF-8BA5-B3E932896D91Q30396308-3A53B3EF-2945-44BF-8D64-FD16DE97F1BDQ30541989-D16A2640-882C-43ED-9A11-1618290897A8Q30881725-43A8EE5C-EC65-45E4-AC64-56A119C55288Q33663090-266C401F-5A0D-4CDB-AE0F-2EFE5CAC1173Q33751680-485A0739-1936-4013-A0FB-91250E8E67FFQ33856282-E2686023-F792-4174-A230-DC7CD1BA8D21Q33859025-557EAA54-2FAE-493F-9B1C-EC175846FC06Q34106989-8A455554-3F7C-4FA6-A6D8-6A48BE7C671BQ34142129-19D40B07-CEFC-4528-B911-1B891538BC3DQ34143916-A0CFD539-5088-4DFC-AAF7-6CCAC1AD4BB9Q34195633-83B8CEB9-ED09-4443-A94B-E261F387C2D5Q34201311-EEB5CA72-841D-41C3-BB06-1C607701F5A0Q34266074-2E58FD87-FDC4-44E8-AD83-1139A25F85C1Q34319946-2418B010-E1C0-4CAF-BF45-D36BC303283DQ34974437-45B545F0-8FD1-4D8B-AF44-D0495B0E4DFCQ34991503-32F3E65D-0B59-44F1-96F9-FFE9B21215EBQ35082753-8492B243-CD50-486C-B4D3-8C2E2AE05BFAQ35124477-DECF19C1-E7E0-4333-BAF2-0BD549E3AEB7Q35207138-56811335-3C07-4CEC-A59B-279912D6BAC1Q35356144-880CBB56-4077-401C-B11C-576D7463EF33Q35609122-8F8F97DB-8361-4805-9718-F3B73D4EBD61Q35981753-F95E78DE-0FDA-41E4-9181-5F73FDB628E4Q35995546-3A7DD450-A5EB-4E00-A851-EB1859F21113Q36343438-A3A23074-9893-4E34-A282-11238F706BC0Q36670187-A24C9730-A4AB-4C66-8750-3AB581DE9C29Q36788831-80235FC1-9FE2-4EE1-A878-EEC63EE0143DQ36949536-8F96AB12-36DA-42D4-8B3B-9C90B076362FQ36969991-BEF10290-D5FC-47A0-8E32-0330E2518FEFQ37511391-C260C025-0B10-48CE-983D-EF63F47AAE34Q37568924-A3D57655-7710-4823-8475-539837F45FE1Q37742720-30FE778A-F8E2-4C0F-AC3C-2E1D29E6D24AQ37853844-B151B446-08F9-4E64-A9F8-B62EACC86284Q38241417-14CDDCAF-E15E-466C-A44B-6D6206E1A8DBQ38286351-0D9AC153-E2FC-41E4-A110-7F3F9320260CQ39304670-052FD461-E9AE-4D73-BE93-AB1EBFC0AB4EQ39485062-4C251DA1-3A63-4E40-A82F-F1539826AC65Q40044256-5AF4AA31-A22A-47C3-AEB1-6A1EDFA212BDQ40049619-813B2C08-7047-4724-B90C-6870B7E19C49
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Detection of beta-lactamase-mediated resistance.
@en
Detection of beta-lactamase-mediated resistance.
@nl
type
label
Detection of beta-lactamase-mediated resistance.
@en
Detection of beta-lactamase-mediated resistance.
@nl
prefLabel
Detection of beta-lactamase-mediated resistance.
@en
Detection of beta-lactamase-mediated resistance.
@nl
P356
P1476
Detection of beta-lactamase-mediated resistance.
@en
P2093
Livermore DM
P356
10.1093/JAC/48.SUPPL_1.59
P407
P478
48 Suppl 1
P577
2001-07-01T00:00:00Z